Histologic heterogeneity predicts patient prognosis of HER2‐positive metastatic breast cancer: A retrospective study based on SEER database

BACKGROUND: Human epidermal growth factor receptor 2‐positive (HER2+) metastatic breast cancer (MBC) is a subtype of breast cancer with a worse prognosis. Little is known about the relationship between histology and prognosis among different distant metastasis sites (DMS). Our aims were to explore t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yajie, Liang, Yiran, Ye, Fangzhou, Luo, Dan, Jin, Yuhan, Li, Yaming, Zhao, Wenjing, Chen, Bing, Wang, Lijuan, Yang, Qifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557902/
https://www.ncbi.nlm.nih.gov/pubmed/37605516
http://dx.doi.org/10.1002/cam4.6469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557902/
https://www.ncbi.nlm.nih.gov/pubmed/37605516
http://dx.doi.org/10.1002/cam4.6469

Ejemplares similares